BAC stock · QNCX stock

BAC vs QNCX · P/E 13, rev $31.56B vs $79.3M cap

Bank of America Corp (BAC) versus Quince Therapeutics, Inc. (QNCX) — a side-by-side from cached financials, not a winner call.

Bank of America Corp (BAC) is a banks - diversified company listed on US. It is led by Brian Thomas Moynihan.

Quince Therapeutics, Inc. (QNCX) is a biotechnology company listed on US.

Latest reported BAC revenue for 2026-06-30 was $31.56B. Net income was $9.07B. Revenue was up 4.2% from 2026-03-31 to 2026-06-30. BAC currently screens at market cap $382.01B and trailing P/E 13.4.

QNCX does not have a complete income-statement cache yet.

BAC currently screens at market cap $382.01B and trailing P/E 13.4. QNCX currently screens at market cap $79.3M.

Not investment advice. Open the BAC and QNCX stock pages for the full models.

Not investment advice.

Popular Stock Comparisons